anmelden
SMI Expanded
1.957,36
PKT
+6,83
PKT
+0,35
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.10.12 | Schindler hold | Vontobel Research | |
| 29.10.12 | UBS neutral | UBS AG | |
| 29.10.12 | Julius Bär buy | UBS AG | |
| 29.10.12 | UBS hold | Vontobel Research | |
| 29.10.12 | UBS neutral | Sarasin Research | |
| 29.10.12 | SGS SA buy | Vontobel Research | |
| 29.10.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 29.10.12 | Novartis outperform | Credit Suisse Group | |
| 26.10.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 26.10.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Logitech neutral | UBS AG | |
| 26.10.12 | UBS neutral | Nomura | |
| 26.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | UBS neutral | Exane-BNP Paribas SA | |
| 26.10.12 | UBS equal-weight | Morgan Stanley | |
| 26.10.12 | Clariant buy | Vontobel Research | |
| 26.10.12 | Logitech hold | Vontobel Research | |
| 26.10.12 | Novartis reduce | Vontobel Research | |
| 26.10.12 | UBS neutral | Sarasin Research | |
| 26.10.12 | SGS SA buy | Vontobel Research | |
| 25.10.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 25.10.12 | Schindler neutral | Exane-BNP Paribas SA | |
| 25.10.12 | Novartis buy | Sarasin Research | |
| 25.10.12 | UBS hold | Vontobel Research | |
| 25.10.12 | Logitech neutral | Sarasin Research | |
| 25.10.12 | UBS neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.10.12 | Novartis reduce | Vontobel Research | |
| 25.10.12 | Logitech hold | Vontobel Research | |
| 25.10.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 24.10.12 | Temenos underperform | Cheuvreux SA | |
| 24.10.12 | Novartis underperform | Cheuvreux SA | |
| 24.10.12 | Temenos equal-weight | Morgan Stanley | |
| 24.10.12 | Temenos outperform | Exane-BNP Paribas SA | |
| 24.10.12 | Roche buy | Sarasin Research | |
| 24.10.12 | Temenos buy | Vontobel Research |